Canopy Growth Corporation — Form 8-K Summary
Reporting date: June 22, 2023; filed June 27, 2023. Item: Change in registrant’s certifying accountant.
Business Context and Reporting Period
Canopy Growth Corporation reported the resignation of KPMG LLP as its independent registered public accounting firm, effective June 22, 2023. The filing addresses the fiscal years ended March 31, 2023 and March 31, 2022, and the interim period through June 22, 2023.
Financial Condition and Key Accounting Matters
- The filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity figures.
- KPMG’s audit report on the fiscal 2023 consolidated financial statements included a going-concern paragraph citing material short-term debt obligations, recurring operating losses, and the need for additional capital to fund operations.
- The fiscal 2023 financial statements included an explanatory paragraph concerning the restatement of the fiscal 2022 consolidated financial statements.
- The fiscal 2023 financial statements did not include adjustments that might result from the going-concern uncertainty.
Material Changes Versus Prior Comparable Period
- KPMG’s report on internal control over financial reporting as of March 31, 2023 contained an adverse opinion.
- Management identified material weaknesses involving the control environment, revenue recognition and related accounting in the BioSteel segment, goodwill impairment timing, redeemable noncontrolling interest, and information-technology general controls.
- The company restated its fiscal 2022 audited financial statements and its unaudited quarterly financial statements for the quarters ended June 30, September 30, and December 31, 2022. Related management’s discussion and analysis was amended in the fiscal 2023 Form 10-K.
- PKF O’Connor Davies, LLP was engaged on June 22, 2023 as the company’s independent registered public accounting firm for the fiscal year ending March 31, 2024.
Management Commentary, Risks, and Unusual Items
- The ineffective control environment was attributed in part to insufficient trained operational and IT personnel with appropriate skills, authority, responsibility, and accountability.
- BioSteel control deficiencies included inadequate review of customer orders, insufficient approval controls for sales returns, and ineffective revenue-recognition policies and procedures. These deficiencies contributed to material misstatements in revenue and trade receivables and delayed recognition of BioSteel goodwill impairment.
- IT deficiencies included weaknesses in logical access management, payroll-system change management, and monitoring of third-party service organizations. The filing states that no adverse effects were identified, but dependent business processes and data could be adversely affected.
- The company stated that there were no disagreements with KPMG regarding accounting principles, disclosures, or audit scope and procedures.
- The company stated that, other than the disclosed internal-control deficiencies and restatements, there were no reportable events through June 22, 2023.
- KPMG was authorized to respond fully to inquiries from PKF O’Connor Davies regarding the disclosed reportable events. KPMG’s related letter to the SEC is filed as Exhibit 16.1.
Key Facts for Investors to Verify
- The amounts and maturities of Canopy Growth’s short-term debt obligations and its available liquidity and financing plans.
- The scope and effects of the fiscal 2022 and quarterly financial-statement restatements.
- The financial impact of BioSteel revenue-recognition errors, goodwill impairment, and redeemable noncontrolling-interest adjustments.
- Management’s remediation progress for the disclosed material weaknesses and the timing of any future effectiveness assessment.
- The terms and conclusions of KPMG’s Exhibit 16.1 letter and any subsequent disclosures from the successor auditor.